发明名称 BIOACTIVE SUBSTANCE
摘要 NEW MATERIAL:A bioactive substance MP-A produced by a Staphylococcus aureus and having the following properties; Molecular weight: 1X10<4> dalton(SDS- PAGE method), Bioactivity: significantly high activity of lymphocyte transformation to human peripheral blood mononuclear cyte, production of interleukin-2, cytotoxicity and induction of IgG production, Solubility: soluble at >=pH4 and precipitate at <=pH3.5, Adsorptivity: adsorbed on strong ion exchanger. USE:A remedy of severe infectious diseases, virus infectious diseases, malignant tumor, etc. PREPARATION:For example, Staphylococcus aureus Cowan III type is cultured and the bacterium is crushed using an ultrasonic disintegrator followed by centrifugation for separation of the supernatant. The separated supernatant is ultrafiltrated for concentration and the resultant concentrated solution is dialyzed and subsequently subjected to the affinity chromatography method using a human IgG-bonded agarose column to collect the non-adsorbed fraction. To the obtained non-adsorbed fraction ammonium sulfate is added and the resultant precipitate is collected and redissolved. The obtained solution is fractionated using a strong ion exchange column for purification, thus obtaining the objective bioactive substance MP-A.
申请公布号 JPH02150291(A) 申请公布日期 1990.06.08
申请号 JP19880300978 申请日期 1988.11.30
申请人 FUJIREBIO INC 发明人 KOYAMAISHI YOSHIHIRO;MIZUKOSHI MIKIO;MIYAKOSHI HIDEO;SUGIMOTO MASAZUMI
分类号 C12P21/00;A61K35/74;A61P31/04;A61P31/12;A61P35/00;A61P37/00;C07K14/005;C07K14/195;C07K14/41;C07K14/52;C12R1/445 主分类号 C12P21/00
代理机构 代理人
主权项
地址